Clinical Trial Update: Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating ranolazine for arrhythmias and microvolt T-wave alternans in patients with left ventricular dysfunction. The trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Cardiac Death
• Ventricular Arrhythmias

Drugs mentioned

• Ranexa (ranolazine)

Snippet

Sponsor: Aspirus Heart and Vascular Institute-Research and Education | Conditions: Sudden Cardiac Death, Ventricular Arrythmias | Phase 3 | Status: COMPLETED